Tschantre Eujeania Dorsett, MD | |
1500 E Downing St Ste 208, Tahlequah, OK 74464 | |
(918) 456-2496 | |
(918) 456-7108 |
Full Name | Tschantre Eujeania Dorsett |
---|---|
Gender | Female |
Speciality | Obstetrics/gynecology |
Experience | 16 Years |
Location | 1500 E Downing St Ste 208, Tahlequah, Oklahoma |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1417117565 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207V00000X | Obstetrics & Gynecology | 26403 (Oklahoma) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Cherokee Nation W W Hastings Indian Hospital | Tahlequah, OK | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Cherokee Nation | 5799698742 | 329 |
News Archive
UnitedHealthcare, a UnitedHealth Group company, announced a new program that will enable enrollees in the company's market-leading Medicare plans to save money on hundreds of prescription medications in 2011.
SARcode Bioscience, Inc., a privately-held biopharmaceutical company, announced today the completion of a $44 million Series B private equity financing. The financing round was led by Sofinnova Ventures and was augmented by the additional backing of Rho Ventures and existing investors Alta Partners and Clarus Venture Partners.
Creating bacterial "fight clubs" is an effective way to find new drugs from natural sources. That is the conclusion of a team of Vanderbilt chemists who have been exploring ways to get bacteria to produce biologically active chemicals that they normally hold in reserve. These compounds are called secondary metabolites.
A groundbreaking new report from the American Autoimmune Related Diseases Association, examining the current state of autoimmune disease (AD) and its economic and social impact globally and in the U.S., was released today at the National Autoimmune Diseases Summit: The Global State of Autoimmunity Today, held to kick-off National Autoimmune Disease Awareness Month.
› Verified 7 days ago
Entity Name | Cherokee Nation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1780692723 PECOS PAC ID: 5799698742 Enrollment ID: O20031106000628 |
News Archive
UnitedHealthcare, a UnitedHealth Group company, announced a new program that will enable enrollees in the company's market-leading Medicare plans to save money on hundreds of prescription medications in 2011.
SARcode Bioscience, Inc., a privately-held biopharmaceutical company, announced today the completion of a $44 million Series B private equity financing. The financing round was led by Sofinnova Ventures and was augmented by the additional backing of Rho Ventures and existing investors Alta Partners and Clarus Venture Partners.
Creating bacterial "fight clubs" is an effective way to find new drugs from natural sources. That is the conclusion of a team of Vanderbilt chemists who have been exploring ways to get bacteria to produce biologically active chemicals that they normally hold in reserve. These compounds are called secondary metabolites.
A groundbreaking new report from the American Autoimmune Related Diseases Association, examining the current state of autoimmune disease (AD) and its economic and social impact globally and in the U.S., was released today at the National Autoimmune Diseases Summit: The Global State of Autoimmunity Today, held to kick-off National Autoimmune Disease Awareness Month.
› Verified 7 days ago
Entity Name | Cherokee Nation |
---|---|
Entity Type | Part B Supplier - Ambulatory Surgical Center |
Entity Identifiers | NPI Number: 1669628707 PECOS PAC ID: 5799698742 Enrollment ID: O20090302000149 |
News Archive
UnitedHealthcare, a UnitedHealth Group company, announced a new program that will enable enrollees in the company's market-leading Medicare plans to save money on hundreds of prescription medications in 2011.
SARcode Bioscience, Inc., a privately-held biopharmaceutical company, announced today the completion of a $44 million Series B private equity financing. The financing round was led by Sofinnova Ventures and was augmented by the additional backing of Rho Ventures and existing investors Alta Partners and Clarus Venture Partners.
Creating bacterial "fight clubs" is an effective way to find new drugs from natural sources. That is the conclusion of a team of Vanderbilt chemists who have been exploring ways to get bacteria to produce biologically active chemicals that they normally hold in reserve. These compounds are called secondary metabolites.
A groundbreaking new report from the American Autoimmune Related Diseases Association, examining the current state of autoimmune disease (AD) and its economic and social impact globally and in the U.S., was released today at the National Autoimmune Diseases Summit: The Global State of Autoimmunity Today, held to kick-off National Autoimmune Disease Awareness Month.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Tschantre Eujeania Dorsett, MD Po Box 751, Hulbert, OK 74441-0751 Ph: (918) 772-3390 | Tschantre Eujeania Dorsett, MD 1500 E Downing St Ste 208, Tahlequah, OK 74464 Ph: (918) 456-2496 |
News Archive
UnitedHealthcare, a UnitedHealth Group company, announced a new program that will enable enrollees in the company's market-leading Medicare plans to save money on hundreds of prescription medications in 2011.
SARcode Bioscience, Inc., a privately-held biopharmaceutical company, announced today the completion of a $44 million Series B private equity financing. The financing round was led by Sofinnova Ventures and was augmented by the additional backing of Rho Ventures and existing investors Alta Partners and Clarus Venture Partners.
Creating bacterial "fight clubs" is an effective way to find new drugs from natural sources. That is the conclusion of a team of Vanderbilt chemists who have been exploring ways to get bacteria to produce biologically active chemicals that they normally hold in reserve. These compounds are called secondary metabolites.
A groundbreaking new report from the American Autoimmune Related Diseases Association, examining the current state of autoimmune disease (AD) and its economic and social impact globally and in the U.S., was released today at the National Autoimmune Diseases Summit: The Global State of Autoimmunity Today, held to kick-off National Autoimmune Disease Awareness Month.
› Verified 7 days ago
Lana Dawn Myers, D.O. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1201 East Ross Bypass, Tahlequah, OK 74464 Phone: 918-207-0991 Fax: 918-456-7570 | |
Dr. David Richard Gahn, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 100 S Bliss Ave, Hastings Indian Medical Center, Tahlequah, OK 74464 Phone: 918-458-3360 Fax: 918-458-3315 | |
Dr. Greggory Jon Woitte, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 100 S Bliss Ave, Tahlequah, OK 74464 Phone: 918-458-3130 Fax: 918-458-3315 | |
Dr. Calvin P. Monroe, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1500 E Downing St Ste 208, Tahlequah, OK 74464 Phone: 918-456-2496 Fax: 918-456-7108 | |
Wallace Jackson Champlain, DO Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1500 E Downing St Ste 208, Tahlequah, OK 74464 Phone: 918-456-2496 Fax: 918-456-7108 | |
Dr. William Trousdale, Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 100 S Bliss Ave, Tahlequah, OK 74464 Phone: 918-458-3100 |